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Abstract
Background: Streptococcus pneumoniae is the leading cause of community-acquired pneumonia.
Previously, using comparative genomic analyses, 13 regions of genomic plasticity have been
identified in the S. pneumoniae genome. These "Regions of Diversity" (RDs) accounted for half the
genomic variation observed amongst all pneumococci tested, moreover, were determined to
encode a variety of putative virulence factors. To date, genes within 5 RDs have been unequivocally
demonstrated to contribute to S. pneumoniae virulence. It is unknown if the remaining RDs also
contribute to virulence.
Results: Using allelic exchange, we created S. pneumoniae mutants that were deficient in RD2, 5,
7, 8, 9, 12 and 13. Mutants deficient in RD8, 9 and 13 were attenuated in a mouse model of disease.
RD8 is 40,358 nucleotides in length and encodes 37 genes. Using a panel of isogenic mutants, we
determined that RD8b3 is the operon within RD8 that is responsible for virulence. Mice infected
with mutants deficient in RD8, RD8b3, RD9 and RD13 had significantly less bacteria in the blood
two days after intranasal challenge and improved survival over time versus mice infected with wild
type. In all instances mutants colonized the nasopharynx at levels equivalent to wild type.
Conclusion: Genes within RD1, 3, 4, 6, and 10 have previously been shown to contribute to
virulence. This study demonstrates that genes within RD8, 9 and 13 also contribute to virulence.
The ability of mutants deficient in RD2, 5, 7, 8, 9, 12, and 13 to colonize the nasopharynx indicates
that genes within these RDs are not required for asymptomatic carriage. Nonetheless, the
observation that mutants deficient in RD8b3, 9 and 13 are attenuated indicates that genes within
these loci are necessary for spread of the bacteria beyond the nasopharynx to normally sterile sites.
Background
Streptococcus pneumoniae (the pneumococcus) is a leading
cause of community-acquired pneumonia, sepsis, and
meningitis. Primarily a commensal, invasive pneumococ-
cal disease (IPD) is characterized by spread of the pneu-
mococcus from the nasopharynx to normally sterile sites
such as the lungs, blood, and central nervous system. At
risk for IPD are young children, the elderly, and individu-
als who are immunocompromised or have underlying
medical conditions such as sickle cell anemia. Worldwide,
it is estimated that S. pneumoniae is responsible for 15
cases of IPD per 100,000 persons per year and over a mil-
lion deaths annually [1,2]. Of note, the preponderance of
invasive disease is the result of infection with a relatively
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few invasive clones [3], a finding that suggests invasive
clones carry genes that facilitate disease progression that
are absent in non-invasive isolates.
In 2001, the primary nucleotide sequence of three S. pneu-
moniae genomes became publicly available [4-6]. In 2004,
comparative genomic hybridization analysis of 10 clinical
isolates using microarrays determined that 13 large loci,
hence forth termed Regions of Diversity (RD1-13),
accounted for half the genomic variation observed among
all pneumococci (approximately 10% of the genome of
each isolate) [7]. Genomic comparisons, performed by
either microarrays or direct sequencing suggested that
these 13 RDs are regions of genome plasticity and are une-
qually distributed among clones and serotype [7,8]. These
findings were confirmed by Bruckner et al., who using
DNA from 20 S. pneumoniae isolates and microarrays,
identified 13 clusters of 4 kb and larger that were not
shared by a variety of genetically different S. pneumoniae
strains [9]. Of the 13 RDs, 7 have been associated with
atypical GC content and 8 have been determined to be
flanked by remnants of mobile genetic elements [7]; find-
ings that indicate these RDs were most likely acquired by
horizontal transfer.
To date, 5 RDs have been conclusively demonstrated by
deletion mutagenesis to contain genes that contribute to
virulence. RD1 encodes ZmpC, a zinc metalloproteinase
that plays a role in pathogenicity of the lung [10,11]. RD3
encodes the capsular polysaccharide synthesis operon;
capsule is an absolute requirement for virulence [12]. RD4
encodes the pathogenicity islet rlrA [13,14]; rlrA isrespon-
sible for the formation of pilus-like structures on the sur-
face of the bacteria. Mutants deficient in rlrA  are
attenuated in their ability to adhere to cell lines in vitro,
colonize the nasopharynx and progress to pneumonia
and bacteremia in mice [15]. RD6 encodes Pneumococcal
Pathogenicity Island 1 (PPI1) [16]. Virulence genes within
PPI1 include, piaABCD, an iron acquisition locus,
phgABC, an operon required for growth in hyperosmotic
medium such as blood and serum, and SP1051, a gene
with unknown function [16-19]. Finally, RD10 encodes
the pathogenicity island psrP-secY2A2  [8].  psrP-secY2A2
encodes the serine-rich repeat adhesin PsrP. Disruption of
psrP resulted in a mutant unable to establish lower respi-
ratory tract infection and delayed in its ability to enter the
bloodstream. Table 1 describes the 13 RDs identified in S.
pneumoniae. A list of all the genes within these RDs and
their function based on sequence homology has been pre-
viously described [8].
In this investigation we examined the remaining unchar-
acterized RDs (RD2, 5, 7, 8, 9, 11, 12, and 13) to deter-
mine if they contribute to virulence. Using allelic
exchange we created isogenic deletion mutants deficient
in these RDs (with exception to RD11) and determined
their ability to colonize the nasopharynx and cause inva-
sive disease in mice. We concluded that genes within RD8,
9 and 13 contributed to S. pneumoniae virulence and that
none of the RDs examined were required for nasopharyn-
geal colonization. Finally, RD8 is composed of two path-
ogenicity islands. These have previously been designated
RD8a and RD8b (Figure 1) [8]. We show that genes within
the third operon of RD8b, RD8b3, encoded the genes
responsible for RD8 virulence.
Schematic representation of RD8 Figure 1
Schematic representation of RD8. RD8 is composed of two adjacent pathogenicity islands RD8a and RD8b [8]. Operons 
within RD8a and RD8b are shown.
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Results
Challenge of mice with S. pneumoniae mutants deficient 
in RD
To determine if genes within RD2, 5, 7, 8, 9, 12, and 13
were required for virulence, cohorts of at least 10 BALB/cJ
mice were infected intranasally with 107 cfu of TIGR4 and
TIGR4 RD deficient mutants (T4 ΩRD). Mice were moni-
tored for 10 days after challenge and bacterial titers in the
blood determined on days 2, 4, 7, and 10. Two days post-
challenge bacterial titers in the blood were significantly
reduced in mice challenged with T4 ΩRD8, T4 ΩRD9 and
T4 ΩRD13 (Figure 2). In contrast, mice challenged with
T4 ΩRD2, T4 ΩRD5, T4 ΩRD7, and T4 ΩRD12 had bacte-
rial titers in the blood equivalent to wild type. Mice
infected with T4 ΩRD8 and T4 ΩRD9 also had signifi-
cantly lower bacterial titers on day 4 (T4 ΩRD8: p = 0.008;
T4 ΩRD9: p = 0.021), after which an insufficient number
of wild type infected mice remained alive for comparison
(Figure 3). Of note, significantly lower bacterial titers in
the blood at day 2 corresponded with improved survival
over time versus infected controls; a finding that indicates
genes within RD8, RD9 and RD13 contributed towards
virulence.
Nasopharyngeal colonization
The attenuated phenotype observed with T4 ΩRD8, T4
ΩRD9 and T4 ΩRD13 may be the result of an inability of
the mutants to colonize the nasopharynx. To test the con-
tribution of all the RDs to nasopharyngeal colonization,
we infected mice intranasally with a sublethal dose of S.
pneumoniae  (104 cfu) and examined the ability of the
mutants to persist in the nasopharynx for up to 2 weeks.
No differences were observed in the number of bacteria
present in nasopharyngeal lavage elute obtained from
Bacteria titers in the blood of mice challenged with RD defi- cient S. pneumoniae Figure 2
Bacteria titers in the blood of mice challenged with 
RD deficient S. pneumoniae. Mice were challenged with 
107 cfu of TIGR4 and its isogenic RD mutants. Two days 
post-challenge, blood was collected from the tail vein of each 
mouse and the number of bacteria in the blood determined. 
Each circle represents the bacterial titer of an individual 
mouse. Bars indicate the median bacterial titer. Statistical 
analysis was performed using a Mann Whitney Rank Sum 
Test
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Table 1: Regions of Diversity in S. pneumoniae and their function
Regions of Diversity† % GC content Genes included in RD: 
TIGR annotation
Size (Kbp) Encoded virulence 
determinants
Ref. cited
Characterized:
RD1 Typical SP0067-75 10.0 ZmpC; zinc 
metalloproteinase C
10,11
RD3 Atypical SP0346-360 16.4 capsular polysacharide 
synthesis operon
12
RD4 Typical SP0641-649 18.5 RlrA pathogenicity 
islet
13–15
RD6 Highly Atypical SP1028-1065 30.3 PPI1, pneumococcal 
pathogenicity island I
16–19
RD10 Highly Atypical SP1755-1772 36.2 PsrP-secY2A2 
pathogenicity island
8
Uncharacterized:
RD2 Typical SP0163-171 6.3 n/a
RD5 Typical SP0691-700 4.9 n/a
RD7 Atypical SP1129-1147 10.6 n/a
RD8 Atypical SP1315-1351 40.3 n/a
RD9 Typical SP1612-1622 9.8 n/a
RD11 Atypical SP1828-1831 3.7 n/a
RD12 Highly Atypical SP1947-1957 11.1 n/a
RD13 Typical SP2158-2166 10.9 n/a
†As described by Tettelin et al. [4, 7].BMC Microbiology 2007, 7:80 http://www.biomedcentral.com/1471-2180/7/80
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mice challenged with the RD mutants and wild type 2, 7,
and 14 days after challenge (Table 2). Thus genes within
RD2, 5, 7, 8, 9, 12, and 13 did not contribute to nasopha-
ryngeal colonization.
Challenge of mice with S. pneumoniae mutants deficient 
in RD8 operons
RD8 is greater than 40,000 nucleotides in length and
encodes 37 genes divided into 5 operons (Figure 1). Pre-
viously, using comparative genomic analyses, we deter-
mined that RD8 is composed of two pathogenicity
islands, RD8a and RD8b, that are adjacent to each other
on the TIGR4 chromosome [8]. To determine which of
these pathogenicity islands were required for virulence we
created two mutants, one deficient in RD8a, which lacked
the genes SP1315 to SP1331, and one deficient in RD8b
which lacked the genes SP1332 to SP1351, and tested the
ability of these mutants to cause disease. Two days post-
challenge mice infected with T4 ΩRD8b had bacterial tit-
ers in the blood significantly lower than mice infected
with TIGR4, whereas mice infected with T4 ΩRD8a had
bacterial titers in the blood comparable to wild type (Fig-
ure 4). As with T4 ΩRD8, lower bacterial titers of T4
ΩRD8b in the blood corresponded with improved sur-
vival (Figure 5). All mice infected with RD8a died within
5 days of challenge (n = 11), whereas 91% (n = 11) of
those infected with T4 ΩRD8b survived past day 10.
To determine the operon(s) within RD8b that were
responsible for virulence, we created isogenic mutants
deficient in the operons RD8b1, RD8b2 and RD8b3 and
challenged mice with these mutants. Deletion of RD8b1
or RD8b2 failed to have a statistically significant impact
on virulence. Mice infected with T4 ΩRD8b1 and T4
ΩRD8b2 had bacterial titers in the blood equivalent to
wild type at day 2 and a survival rate comparable to wild
type infected mice (Figure 4 and 5). In contrast, deletion
of RD8b3 attenuated TIGR4 virulence. Mice infected with
T4 ΩRD8b3 had 40-fold less bacteria in the blood than
mice infected with TIGR4 (Figure 4), and demonstrated
improved survival over time (Figure 5). Thus genes within
RD8b3 were in large part responsible for the virulence
associated with RD8.
Unlike deletion of RD8b1-3 (T4 ΩRD8b), it is of note that
deletion of RD8b3 did not completely attenuate TIGR4
virulence. Moreover, the mutant T4 ΩRD8b1 was not fully
virulent. At day 2 mice infected with T4 ΩRD8b1 had a
median bacterial titer in the blood 10-fold lower than
wild type (p = 0.337), likewise, mice infected with T4
ΩRD8b1 demonstrated a delay in time of death (p =
0.09), albeit these differences were not significant. Thus it
seems that genes within RD8b1 might also contribute to
virulence, but not in a manner sufficient to demonstrate
statistical significance in this challenge model.
TIGR4 growth in media with ribulose and fucose as the sole 
carbon source
Based on nucleotide sequence homology, genes within
RD9 and RD13 encode proteins that transport ribulose
and fucose, respectively (see Discussion). To test this pre-
diction, we determined if deletion of RD9 and RD13
affected the ability of TIGR4 to grow in media containing
either ribulose or fucose as the sole carbon source. In all
instances TIGR4, T4 ΩRD9 and T4 ΩRD13 grew normally
in regular C+Y (0.15% glucose and 0.2% sucrose; data not
shown). However, neither TIGR4 nor the mutants were
able to grow in media containing ribulose (0.1–0.5%) or
fucose (0.1–0.5%) as the sole carbon source (data not
shown). Thus ribulose or fucose is not sufficient to sup-
port TIGR4 growth despite the presence of RD9 and
RD13.
Discussion
It is well established that the propensity of a S. pneumoniae
isolate to cause invasive disease is dependent on the inter-
play between serotype and genotype. Molecular epidemi-
ology has demonstrated that invasive and non-invasive
clones exist within invasive serotypes [20]. Kelly et al.
have shown that conversion of a virulent serotype 5 iso-
Table 2: S. pneumoniae titers in nasopharyngeal lavage elute collected from mice
Day 2 Day 7 Day 14
Strain Median 
(log10)
n p value Median 
(log10)
n p value Median 
(log10)
n p value
T4 6.41 11 6.30 9 5.25 6
RD ΩRD2 6.26 9 0.704 5.47 8 0.175 5.39 8 0.662
RD ΩRD5 6.34 10 0.360 6.11 7 0.751 5.46 6 0.589
RD ΩRD7 6.73 9 0.254 5.48 5 0.149 5.11 5 0.537
RD ΩRD8 6.08 8 0.457 6.11 7 0.125 4.87 7 0.295
RD ΩRD9 6.32 8 0.901 5.95 7 0.368 5.30 7 0.628
RD ΩRD12 6.46 10 0.916 6.20 6 0.095 5.68 6 0.240
RD ΩRD13 6.38 7 0.556 6.30 7 0.397 4.96 7 0.945BMC Microbiology 2007, 7:80 http://www.biomedcentral.com/1471-2180/7/80
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late to serotype 3 ablated virulence in mice, whereas con-
version of a 6B isolate to serotype 3 lowered the LD50 by
>100-fold [21]. It is also known that the genomic compo-
nent of virulence (i.e. that excluding genes that encode
capsular polysaccharide) is dependent on the presence of
horizontally acquired genes that complement the core
genome. Previously, we have demonstrated that RDs
known to contribute to virulence are unequally distrib-
uted among invasive and non-invasive isolates in a sero-
type-dependent manner [8]. Likewise, the absence of non-
core, non-RD associated virulence genes, such as those
encoding the adhesin Choline Binding Protein A (CbpA),
have been demonstrated to diminish the ability of an iso-
late to progress from the nasopharynx to the lungs and
bloodstream [22].
To date, RD1, 3, 4, 6 and 10 have been conclusively
shown to contribute to virulence by deletion and disrup-
tion mutagenesis [8,10-16,18,19,23]. The purpose of this
study was to determine if the 8 uncharacterized RDs
(RD2, 5, 7, 8, 9, 11, 12 and 13) also contribute to viru-
lence. Because all 13 RDs are present in TIGR4 [4], we
chose to use it as the parent strain for these analyses.
The fact that we were able to create deletion mutants defi-
cient in RD2, 5, 7, 8, 9, 12 and 13, moreover, that these
mutants colonized the nasopharynx of mice normally,
indicates that genes within these RDs were not essential in
vitro nor required in vivo by TIGR4 for asymptomatic car-
riage. Given that the human nasopharynx is the sole eco-
logical niche of S. pneumoniae, this finding is consistent
Percent survival of mice following challenge with RD8  mutants Figure 5
Percent survival of mice following challenge with 
RD8 mutants. Kaplan-Meier plot illustrating survival of 
mice infected with wild type and RD8 operon deficient 
mutants. Cohorts of 11–12 mice were infected with wild 
type and the RD8 mutants. Survival was recorded over a 10 
day period. Statistical analysis was performed using a Gehan-
Breslow statistic analysis for survival.
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Percent survival of mice following challenge with RD defi- cient S. pneumoniae Figure 3
Percent survival of mice following challenge with RD 
deficient S. pneumoniae. Kaplan-Meier plot illustrating 
survival of mice infected with wild type and RD deficient 
mutants. Cohorts of 10–11 mice were infected with wild 
type and the RD mutants. Survival was recorded over a 10 
day period. Statistical analysis was performed using a Gehan-
Breslow statistic analysis for survival.
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Bacteria titers in the blood of mice challenged with isogenic  mutants of RD8 Figure 4
Bacteria titers in the blood of mice challenged with 
isogenic mutants of RD8. Mice were challenged with 107 
cfu of TIGR4 and isogenic mutants deficient in operons 
within RD8. Two days post-challenge, blood was collected 
from the tail vein and the number of bacteria in the blood 
determined. Each circle represents the bacterial titer of an 
individual mouse. Bars indicate the median bacterial titer. Sta-
tistical analysis was performed using a Mann Whitney Rank 
Sum Test
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with the fact that RDs are not present in all clinical isolates
and serve as accessory genes. Notably, we were unable to
create a mutant deficient in RD11 despite several
attempts. RD11 encodes a protein homologous to the
high affinity phosphate transport system (PstSABC) regu-
latory protein, PhoU. Studies have shown that PstSABC is
expressed in response to low levels of phosphate and that
deletion of PhoU in strain R6X has pleiotropic effects
including delayed growth and an inability to undergo
autolysis [24,25]. Thus, one possible explanation for our
inability to create an RD11 mutant is that its deletion neg-
atively impacts the ability of TIGR4 to acquire phosphate.
Challenge of mice with the panel of RD mutants demon-
strated that genes within RD8b3, 9 and 13 were required
by TIGR4 to cause invasive disease. Given that mutants
deficient in these RD colonized the nasopharynx nor-
mally, it can be inferred that these loci encode virulence
determinants that are not required for colonization but
instead facilitate spread of the bacteria to normally sterile
sites. How these loci contribute to virulence remains to be
determined.
RD8 is composed of two pathogenicity islands located
adjacent to each other on the TIGR4 chromosome. Previ-
ously, using comparative genomic analysis, we deter-
mined that the presence of RD8a was positively correlated
with the ability of serotype 6A and 6B clinical isolates to
cause invasive human disease. Likewise, we determined
that genes within RD8b were correlated with the non-
invasive phenotype [8]. In this manuscript we demon-
strate that deletion of RD8a has no impact on TIGR4 vir-
ulence, whereas deletion of RD8b ablates TIGR4
virulence. Thus a discrepancy exists between the findings
of this study and those from our previous comparative
genomic analysis. One explanation for this discrepancy
may be the differences in strains. Comparative genomic
analyses was performed using 72 clinical isolates of sero-
type 6A, 6B and 14, whereas this study was limited to a
single serotype 4 isolate. Thus it is possible that genotype
(i.e. gene redundancy, transcriptional regulation, etc...)
and serotype dependent factors (i.e. resistance to
opsonophagocytosis, ability to adhere to cells) have a
large impact on the requirement of RDs for virulence. This
would be in accordance with the findings reported by
Kelly et al. that are described above, moreover, explain
why RDs known to be required for virulence in one strain
are not found in others. For example zmpC, a zinc metal-
loproteinase encoded within RD1, is present in only 25%
of clinical isolates [26]. This finding also suggests that it is
not possible to evaluate the role of any single gene or
operon in any single strain or serotype.
Possible roles of RD8b3, RD9 and RD13
The operon RD8b3 is composed of 7 genes: 6 small hypo-
thetical genes (SP1345, SP1347-49, SP1351), a conserved
domain protein (SP1350), and a putative membrane pro-
tein (SP1346). BLASTP analysis of the predicted amino
acid sequence of these genes finds homologues in other
streptococci and gram-positive bacteria, but no indication
of function with exception to SP1346. SP1346 is identi-
fied as a member of the CAAX amino terminal protease
family. Members of this family include the bacteriocin-
like immunity protein PlnP from Lactobacillus plantarum
[27]. PlnP mediates protection against highly charged cat-
ionic proteins that are expressed from the same operon.
Interestingly, SP1345, SP1347, SP1350 are less than 150
amino acids in length and have a pI greater than 9.
SP1349 and SP1351 are less than 100 amino acids in
length have a pI less than 4. Thus, SP1346 may be an
immunity-like protein that protects the bacteria from cat-
ionic and anionic peptides (presumably the hypothetical
proteins), that may serve to impair the host defence.
Future studies are warranted to determine if this is the
case.
RD9 encodes a single operon composed of 11 genes. It
encodes a transketolase, a ribulose phosphate 3-epime-
rase, a sugar phosphotransferase (PTS) system, and a tran-
scriptional terminator. RD13 is also a single operon
composed of 9 genes. It encodes an L-fucose isomerase, a
fucolin-related protein, an L-fucose aldolase, a PTS trans-
port system, and a conserved hypothetical protein. Thus
RD9 and RD13 encode genes that may contribute to ribu-
lose and fucose uptake.
In context with what is known in regards to RD6 (iron
uptake) [18,19,23] and RD11 (phosphate uptake) [24],
the finding that mutants deficient in RD9 and RD13 are
attenuated suggests that acquisition of ribulose and fucose
are essential for TIGR4 during the disease process. Unfor-
tunately, TIGR4 failed to grow in media that contained
ribulose or fucose as the sole carbon source. This finding
brings up the possibility that: 1) ribulose and fucose play
a role in secondary metabolism, which indirectly contrib-
utes to virulence, but alone are not sufficient to support
bacterial growth. 2) That these RDs do not transport sug-
ars and contribute to virulence in an undefined manner.
As with RD8b3, future experiments are warranted to deter-
mine the mechanism by which these loci contribute to vir-
ulence.
Conclusion
The goal of this study was to determine the virulence con-
tribution of the 8 uncharacterized S. pneumoniae RDs.
Having done so, we can now focus future efforts on char-
acterization of genes within RD8b3, RD9 and RD13.
Future studies will focus on the role RD8b3 as a potentialBMC Microbiology 2007, 7:80 http://www.biomedcentral.com/1471-2180/7/80
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bacteriocin-like system that mediates virulence, and the
requirement for fucose and ribulose in vivo. Of the 13 S.
pneumoniae RDs identified by Tettelin et al., and Bruckner,
seven have now been conclusively demonstrated to play a
role in virulence. This strongly suggests that the propen-
sity of an isolate to cause invasive disease is dependent on
the presence of horizontally acquired genes that comple-
ment the core virulence genes present.
Methods
Bacterial strains and components
S. pneumoniae serotype 4, strain TIGR4 [4] and its isogenic
mutants were grown in defined semi-synthetic casein liq-
uid media supplemented with 0.5% yeast extract (C+Y)
[28] and tryptic soy blood agar plates (Remel, Lenexa, KS)
at 37°C in 5% CO2. Mutants with deleted RDs were
grown with erythromycin at 1 µg/ml (Sigma-Aldrich, St.
Louis, MO). Escherichia coli TOP10 cells (Invitrogen,
Carlsbad, CA) containing the vector pCR2.1 (Invitrogen)
and subsequent recombinant plasmids were selected on
Luria Bertani agar plates containing 1 mg/ml erythromy-
cin. Standard molecular techniques were used for plasmid
DNA manipulation and transformation of E. coli [29].
Creation of Region of Diversity (ΩRD) mutants
Mutants were created using a modified version of the
SOEing technique [30]. The erythromycin resistance cas-
sette ermB was PCR amplified from plasmid pTCV-lac [31]
and cloned into the TA cloning vector pCR2.1. DNA frag-
ments representing sequences immediately 5' and 3' of
the RDs targeted for deletion were amplified from TIGR4
genomic DNA and cloned upstream and downstream of
the ermB cassette in pCR2.1. Primers used to amplify the
upstream and downstream fragments were designed to
include restriction sites that allowed direction cloning of
the fragments. Fragments were cloned such that after
transformation, transcription of ermB  was antisense to
that of surrounding genes. Once cloned in Escherichia coli,
mutagenic PCR products (~3 kb) containing the ermB cas-
sette and the two flanking fragments were amplified from
purified plasmid and the DNA construct used to trans-
form TIGR4. Transformation was performed using CSP-2
following standard methods [32]. Erythromycin-resistant
clones were selected on tryptic soy blood agar plates con-
taining 0.5 µg/ml of erythromycin. Deletions were con-
firmed by 1) successful amplification of a PCR product
using primers that flanked the deleted loci, 2) sequencing
of these PCR products, and 3) a failure to amplify genes
located within the deleted RD from chromosomal DNA
isolated from the mutants. Table 3 lists the primers used
to create the mutagenic and the genes deleted as the result
of allelic exchange.
Intranasal challenge model
Five week old female BALB/cJ mice (Jackson Laboratory,
Bar Harbor, ME) were maintained in biosafety level 2
facilities at The University of Texas Health Science Center
in San Antonio. All experiments were performed with
mice under general anaesthesia with inhaled isoflurane
(2.5%; Baxter Healthcare Corp., Deerfield, IL). S. pneumo-
nia, 104 cfu (low dose colonization model) or 107 cfu
(invasive disease model) in 20 µl phosphate buffered
saline (PBS) was administered drop-wise to the external
nares of mice. On day 2, 4, 7 and 10 bacterial titers in the
blood were determined by collection of blood from the
tail vein, serial dilution and plating. Bacterial titers in the
nasopharynx were determined on days 2, 7, and 14 by
serial dilution and plating of nasopharyngeal lavage
obtained by instillation of 20 µl PBS into the right nostril
and collection of elute from the left. Statistical analysis of
bacterial titers was performed using a nonparametric
independent group analysis (Mann-Whitney rank sum).
Ribulose and fucose growth curves
Exponential phase cultures (OD620 = 0.5) of TIGR4, T4
ΩRD9 and T4 ΩRD13 were grown in C+Y, centrifuged,
washed, and suspended in PBS. Borosilicate glass tubes
(15 × 100 mm) containing 5 ml of normal C+Y (0.15%
glucose, 0.2% sucrose), C+Y with ribulose as the sole car-
bon source (0.1–0.5% fucose), and C+Y with fucose as the
sole carbon source (0.1–0.5% fucose) were inoculated
with 100 µl of bacterial suspensions (final concentration:
105 cfu/ml) and grown at 37°C in 5% CO2. Microbial
growth was measured by determining the optical density
of the culture at OD620 on an hourly basis for 6 hours.
Three cultures were measured at each time point for each
of the bacteria tested.
Data analysis
Statistical analysis of mouse survival over time was per-
formed using a Gehan-Breslow statistic analysis for sur-
vival. Statistical analysis of bacterial titers in the blood
and nasal lavage was performed using a Mann-Whitney
Rank Sum Test.
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